Dietary supplementation with seed oil from transgenic Camelina sativa induces similar increments in plasma and erythrocyte DHA and EPA to fish oil in healthy humans

Annette L West, Elizabeth A Miles, Karen A Lillycrop, Lihua Han, Johnathan A Napier, Philip C Calder, Graham C Burdge, Annette L West, Elizabeth A Miles, Karen A Lillycrop, Lihua Han, Johnathan A Napier, Philip C Calder, Graham C Burdge

Abstract

EPA and DHA are required for normal cell function and can also induce health benefits. Oily fish are the main source of EPA and DHA for human consumption. However, food choices and concerns about the sustainability of marine fish stocks limit the effectiveness of dietary recommendations for EPA + DHA intakes. Seed oils from transgenic plants that contain EPA + DHA are a potential alternative source of EPA and DHA. The present study investigated whether dietary supplementation with transgenic Camelina sativa seed oil (CSO) that contained EPA and DHA was as effective as fish oil (FO) in increasing EPA and DHA concentrations when consumed as a dietary supplement in a blinded crossover study. Healthy men and women (n 31; age 53 (range 20-74) years) were randomised to consume 450 mg/d EPA + DHA provided either as either CSO or FO for 8 weeks, followed by 6 weeks washout and then switched to consuming the other test oil. Fasting venous blood samples were collected at the start and end of each supplementation period. Consuming the test oils significantly (P < 0·05) increased EPA and DHA concentrations in plasma TAG, phosphatidylcholine and cholesteryl esters. There were no significant differences between test oils in the increments of EPA and DHA. There was no significant difference between test oils in the increase in the proportion of erythrocyte EPA + DHA (CSO, 12 %; P < 0·0001 and FO, 8 %; P = 0·02). Together, these findings show that consuming CSO is as effective as FO for increasing EPA and DHA concentrations in humans.

Keywords: Camelina sativa; DHA; Dietary supplementation; EPA; Transgenic plants.

Figures

Fig. 1.
Fig. 1.
CONSORT diagram of the destinations of volunteers.

References

    1. Lauritzen L, Brambilla P, Mazzocchi A, et al. (2016) DHA effects in brain development and function. Nutrients 8, 6.
    1. Lauritzen L, Hansen HS, Jorgensen MH, et al. (2001) The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40, 1–94.
    1. Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851, 469–484.
    1. Calder PC (2015) Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr 39, 18S–32S.
    1. Harris WS & Von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
    1. Baker EJ, Miles EA, Burdge GC, et al. (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res 64, 30–56.
    1. Scientific Advisory Committee on Nutrition (2004) Advice on Fish Consumption: Benefits and Risks. TSO: London.
    1. Givens DI & Gibbs RA (2008) Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proc Nutr Soc 67, 273–280.
    1. Givens DI & Gibbs RA (2006) Very long chain n-3 polyunsaturated fatty acids in the food chain in the UK and the potential of animal-derived foods to increase intake. Nutr Bull 31, 104–110.
    1. Burdge GC, Tan SY & Henry CJ (2017) Long-chain n-3 PUFA in vegetarian women: a metabolic perspective. J Nutr Sci 6, e58.
    1. Salem N Jr & Eggersdorfer M (2015) Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Cur Opin Clin Nutr Metabol Care 18, 147–154.
    1. Tocher DR, Betancor MB, Sprague M, et al. (2019) Omega-3 long-chain polyunsaturated fatty acids, EPA and DHA: bridging the gap between supply and demand. Nutrients 11, E89.
    1. Ruiz-Lopez N, Haslam RP, Napier JA, et al. (2014) Successful high-level accumulation of FO omega-3 long-chain polyunsaturated fatty acids in a transgenic oilseed crop. Plant J 77, 198–208.
    1. West AL, Miles EA, Lillycrop KA, et al. (2019) Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans. Br J Nutr 121, 1235–1246.
    1. West AL, Burdge GC & Calder PC (2016) Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial. Br J Nutr 116, 788–797.
    1. West AL, Michaelson LV, Miles EA, et al. (2020) Differential postprandial incorporation of 20:5n-3 and 22:6n-3 into individual plasma triacylglycerol and phosphatidylcholine molecular species in humans. Biochim Biophys Acta Mol Cell Biol Lipids 1865, 158710.
    1. Burdge GC, Wright P, Jones AE, et al. (2000) A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 84, 781–787.
    1. Folch J, Lees M & Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497–509.
    1. Fisk HL, West AL, Childs CE, et al. (2014) The use of gas chromatography to analyze compositional changes of fatty acids in rat liver tissue during pregnancy. J Viz Exp, issue 85, doi: 10.3791/51445.
    1. Burdge GC, Derrick PR, Russell JJ, et al. (2005) Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into human erythrocytes in vivo . Nutr Res 25, 13–19.
    1. Burdge GC, Powell J & Calder PC (2006) Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50–65 years consuming their habitual diets. Br J Nutr 96, 489–500.
    1. Walker CG, Browning LM, Mander AP, et al. (2014) Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans. Br J Nutr 111, 679–89.
    1. Tricon S, Burdge GC, Kew S, et al. (2004) Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80, 614–620.
    1. Griffin BA & Fielding BA (2001) Postprandial lipid handling. Curr Opin Clin NutrMetabol Care 4, 93–98.
    1. Sanders TA, Sullivan DR, Reeve J, et al. (1985) Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 5, 459–465.
    1. Vidgren HM, Agren JJ, Schwab U, et al. (1997) Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32, 697–705.
    1. Oscarsson J & Hurt-Camejo E (2017) Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Lipids Health Dis 16, 149.
    1. Grimsgaard S, Bonaa KH, Hansen JB, et al. (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 66, 649–659.
    1. Stark KD (2008) The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 43, 45–53.
    1. Metherel AH, Armstrong JM, Patterson AC, et al. (2009) Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 81, 23–29.
    1. Skeaff CM, Hodson L & McKenzie JE (2006) Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr 136, 565–569.
    1. Gastaldi M, Lerique B, Verine A, et al. (1991) Effects of ethanol on phospholipid acylation in rat erythrocytes: a model for a biochemical approach to membrane adaptation. Drug Alcohol Depend 28, 277–282.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren